Case number 1:19-cv-02006
Otsuka Pharmaceutical Co., Ltd. et al v. Apotex Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 26, 2022 | 23 | Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 10/26/2022) (5) |
| Oct 23, 2020 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:19-cv-01938-LPS. (ntl) |
| Oct 16, 2020 | 22 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, (2) Plaintiffs' Initial Disclosure Statement Pursuant to Fed. R. Civ. P. 26(a)(1), and (3) Plaintiffs' Initial Disclosures Pursuant to Paragraph 4(a) of the Default Standard for Discovery filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew) |
| Oct 16, 2020 | 21 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Apotex Inc., Apotex Corp., Apotex Pharmachem Inc. and Signa S.A. de C.V.'s Initial Disclosures Pursuant to Rule 26(a)(1) and (2) Defendants Apotex Inc., Apotex Corp., Apotex Pharmachem Inc. and Signa S.A. de C.V.'s Initial Disclosures Under Paragraph 3 of the District of Delaware's Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V..(Francella, Thomas) |
| Oct 16, 2020 | 20 | Proposed Order (25) Docket Text: PROPOSED ORDER (Proposed Scheduling Order) by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew) |
| Oct 16, 2020 | 19 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Andrew C. Mayo regarding revised schedule following October 2, 2020 status conference. (Mayo, Andrew) |
| Oct 5, 2020 | 18 | Notice Requesting Removal of Co-Counsel (7) Docket Text: NOTICE requesting Clerk to remove Douglas W. Cheek as co-counsel. Reason for request: no longer with firm. (Mayo, Andrew) |
| Oct 5, 2020 | 17 | Transcript (35) Docket Text: Official Transcript of Telephone Conference held on October 2, 2020 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, e-mail: Brian_Gaffigan@ded.uscourts.gov. Transcript may be viewed at the court public terminal or ordered and purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 10/26/2020. Redacted Transcript Deadline set for 11/5/2020. Release of Transcript Restriction set for 1/4/2021. (bpg) |
| Oct 2, 2020 | N/A | Order (0) Docket Text: ORAL ORDER: Having reviewed the parties' joint status report (D.I. 26) and for the reasons stated on the October 2, 2020 teleconference IT IS HEREBY ORDERED that the Rule 12(c) motions filed in these consolidated cases concerning non-infringement of the '419 formulation patent are DENIED WITHOUT PREJUDICE. (See C.A. No. 19-1956, D.I. 15; C.A. No. 19-2008, D.I. 12; C.A. No. 19-1938, D.I. 12; C.A. No. 19-1954, D.I. 26). IT IS HEREBY FURTHER ORDERED that the parties shall submit a revised proposed scheduling order, not later than two weeks from today, consistent with the Court's rulings. ORDERED by Judge Leonard P. Stark on 10/2/20. Associated Cases: 1:19-cv-01938-LPS et al. (ntl) |
| Oct 2, 2020 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 10/2/2020. (Court Reporter B. Gaffigan.) Associated Cases: 1:19-cv-01938-LPS et al. (ntl) |
| Sep 30, 2020 | 15 | Exhibit 1-3 (131) |
| Sep 30, 2020 | 15 | Main Document (21) Docket Text: Joint STATUS REPORT by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Exhibit 1-3)(Balick, Steven) |
| Sep 28, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney James B. Monroe,Tyler B. Latcham for H. Lundbeck A/S, for Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 19-cv-02065-LPS,19-cv-01956-LPS, 19-cv-01952-LPS, 19-cv-02008-LPS, 19-cv-01964-LPS,19-cv-02009-LPS, 19-cv-01987-LPS, 19-cv-01954-LPS,19-cv-01965-LPS,19-cv-01955-LPS, 19-cv-02007-LPS, 19-cv-01938-LPS, 19-cv-01939-LPS, 19-cv-02024-LPS,19-cv-01988-LPS, 19-cv-01977-LPS, 19-cv-02080-LPS,19-cv-02006-LPS (myr) |
| Sep 21, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney C. Collette Corser for H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-02080-LPS et al.(kmd) |
| Sep 14, 2020 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER: Having reviewed the dockets in these multiple related matters, and having noted that there are pending motions in some but not all (and some of the motions appear to present similar if not identical issues), IT IS HEREBY ORDERED that the parties shall meet and confer and, no later than September 30, submit a joint status report advising the Court of how they propose the Court proceed in each of these matters. IT IS FURTHER ORDERED that the Court will hold a joint status teleconference in all of these matters on October 2 and 12:00 p.m. The parties shall use the following dial-in information: 877-336-1829 and using the access code 1408971. ORDERED by Judge Leonard P. Stark on 9/14/20. Associated Cases: 1:19-cv-01938-LPS et al. (ntl) |
| Sep 8, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Denise Main for H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-01938-LPS et al.(kmd) |
| Jun 3, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Douglas W. Cheek for H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-01938-LPS et al.(kmd) |
| Jun 1, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (17 in 1:19-cv-02024-LPS, 12 in 1:19-cv-01977-LPS, 17 in 1:19-cv-01952-LPS, 13 in 1:19-cv-01964-LPS, 14 in 1:19-cv-01956-LPS, 14 in 1:19-cv-01988-LPS, 11 in 1:19-cv-02008-LPS, 18 in 1:19-cv-01938-LPS, 15 in 1:19-cv-01955-LPS, 14 in 1:19-cv-02007-LPS, 12 in 1:19-cv-02009-LPS, 12 in 1:19-cv-01939-LPS, 11 in 1:19-cv-02065-LPS, 13 in 1:19-cv-02006-LPS, 12 in 1:19-cv-01965-LPS, 23 in 1:19-cv-01954-LPS, 15 in 1:19-cv-02080-LPS, 14 in 1:19-cv-01987-LPS) MOTION for Pro Hac Vice Appearance of Attorney Douglas W. Cheek filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 6/1/20. Associated Cases: 1:19-cv-01938-LPS et al. (ntl) |
| May 29, 2020 | 13 | Motion for Leave to Appear Pro Hac Vice (14) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Douglas W. Cheek - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew) |
| Apr 23, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Erin M. Sommers for H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-01938-LPS et al.(kmd) |
| Mar 13, 2020 | 12 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings, Inc. for Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V. filed by Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V.. (Francella, Thomas) |
| Mar 13, 2020 | 11 | Answer to Complaint (18) Docket Text: ANSWER to [1] Complaint, by Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V..(Francella, Thomas) |
| Mar 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (8 in 1:19-cv-02065-LPS, 9 in 1:19-cv-01956-LPS, 13 in 1:19-cv-01952-LPS, 9 in 1:19-cv-02008-LPS, 9 in 1:19-cv-01964-LPS, 8 in 1:19-cv-02009-LPS, 12 in 1:19-cv-01987-LPS, 21 in 1:19-cv-01954-LPS, 8 in 1:19-cv-01965-LPS, 10 in 1:19-cv-01955-LPS, 8 in 1:19-cv-02007-LPS, 10 in 1:19-cv-01938-LPS, 10 in 1:19-cv-01939-LPS, 10 in 1:19-cv-02024-LPS, 11 in 1:19-cv-01988-LPS, 11 in 1:19-cv-01977-LPS, 10 in 1:19-cv-02080-LPS, 10 in 1:19-cv-02006-LPS) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, Tyler B. Latcham, and C. Collette Corser filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 3/5/20. Associated Cases: 1:19-cv-01938-LPS et al. (ntl) |
| Mar 2, 2020 | 10 | Motion for Leave to Appear Pro Hac Vice (18) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, Tyler B. Latcham, and C. Collette Corser - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew) |
| Jan 23, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] Stipulated Order filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 1/23/20. (ntl) |
| Jan 16, 2020 | 9 | Stipulation (2) Docket Text: STIPULATION Regarding Waivers of Service and Establishment of Answer Deadlines, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) |
| Jan 13, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Kerry B. McTigue, William B. Coblentz, Barry P. Golob, Aaron S. Lukas for Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Jan 10, 2020 | 8 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kerry B. McTigue, W. Blake Coblentz, Barry P. Golob, and Aaron S. Lukas - filed by Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V.. (Francella, Thomas) |
| Jan 10, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] MOTION for Pro Hac Vice Appearance of Attorney Kerry B. McTigue, W. Blake Coblentz, Barry P. Golob, and Aaron S. Lukas filed by Apotex Pharmachem Inc., Signa S.A. de C.V., Apotex Inc., Apotex Corp. Signed by Judge Leonard P. Stark on 1/10/2020. (ntl) |
| Jan 10, 2020 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Apotex Corp. on 1/10/2020; Apotex Inc. on 1/10/2020; Apotex Pharmachem Inc. on 1/10/2020; Signa S.A. de C.V. on 1/10/2020. (apk) |
| Jan 9, 2020 | 7 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Thomas Joseph Francella, Jr on behalf of Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V. (Francella, Thomas) |
| Oct 30, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:19-cv-02006-LPS, 1:19-cv-02007-LPS, 1:19-cv-02008-LPS, 1:19-cv-02009-LPS, 1:19-cv-02024-LPS (rjb) |
| Oct 23, 2019 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (kmd) |
| Oct 23, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd. (kmd) |
| Oct 23, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,307,419. (kmd) |
| Oct 23, 2019 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 19, 2019. Date of Expiration of Patent: October 12, 2032.Thirty Month Stay Deadline: 1/10/2023. (kmd) |
| Oct 23, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Oct 23, 2019 | 1 | Civil Cover Sheet (3) |
| Oct 23, 2019 | 1 | Exhibit A (16) |
| Oct 23, 2019 | 1 | Main Document (12) Docket Text: COMPLAINT for Patent Infringement filed against Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2762071.) - filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(kmd) |
| Oct 23, 2019 | 1 | Complaint* (1) |
| Oct 23, 2019 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (kmd) |
